| 1 |
35018944 | Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1/AMPK pathway in vitro and in vivo. | 2022 Feb 7 |
2 |
| 2 |
35150861 | Ginsenoside Rd ameliorates high glucose-induced retinal endothelial injury through AMPK-STRT1 interdependence. | 2022 May |
1 |
| 3 |
30475650 | Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways. | 2019 Aug |
1 |
| 4 |
31467529 | Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-κB Pathway. | 2019 |
1 |
| 5 |
29324976 | Ginsenoside Rg1 inhibits apoptosis by increasing autophagy via the AMPK/mTOR signaling in serum deprivation macrophages. | 2018 Feb 1 |
1 |
| 6 |
21971952 | Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice. | 2012 Jan |
2 |
| 7 |
20118562 | Ginsenoside Rg1 suppresses hepatic glucose production via AMP-activated protein kinase in HepG2 cells. | 2010 |
1 |
| 8 |
19182950 | Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. | 2009 Feb 25 |
1 |